J. Campistol

发表

Successful use of nonantigen‐specific immunoadsorption with antihuman Ig‐columns in kidney graft antibody‐mediated rejection

F. Diekmann, E. Montagud-Marrahi, I. Revuelta, 2020, Journal of clinical apheresis.

Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2).

P. Fernández-Llama, E. Ars, J. Ballarín, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.

J. Campistol, F. Cofán, E. Rosich, 2007, Transplantation proceedings.

Bioimpedance-guided fluid management in hemodialysis patients.

J. Campistol, P. Wabel, U. Moissl, 2013, Clinical journal of the American Society of Nephrology : CJASN.

[Kt as control and follow-up of the dose at a hemodialysis unit].

J. Campistol, M. Arias, M. Carrera, 2008, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells

J. C. Belmonte, I. Sancho-Martinez, Keiichiro Suzuki, 2013, Nature Cell Biology.

Mathematical Modeling of Different Molecule Removal on On-Line Haemodiafiltration: Influence of Dialysis Duration and Infusion Flow

J. Campistol, M. Arias-Guillén, F. Maduell, 2015, Blood Purification.

Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction

P. Magistretti, J. I. Izpisúa Belmonte, C. López-Otín, 2019, Cell Research.

Effect of apolipoprotein E polymorphism on renal transplantation.

E. Ros, F. Oppenheimer, J. Campistol, 2007, Transplantation proceedings.

Rapid calcitriol increase and persistent calcidiol insufficiency in the first 6 months after kidney transplantation

D. Rubello, P. Colletti, D. Fuster, 2015, Nuclear medicine communications.

In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation

J. C. Belmonte, C. R. Esteban, P. Reddy, 2017, Cell.

Interferon β, nephrotic syndrome and thrombotic microangiopathy

L. Quintana, J. Campistol, 2015 .

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.

J. Squifflet, D. Abramowicz, F. Berthoux, 2000, Transplantation.

Lineage Reprogramming Toward Kidney Regeneration

J. C. Belmonte, N. Montserrat, J. Campistol, 2017 .

The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics

E. Gratacós, F. Crispi, M. Díaz-Ricart, 2022, Life.

Incidence of anemia in sirolimus‐treated renal transplant recipients: the importance of preserving renal function *

G. Russ, J. Chapman, P. Friend, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.

J. Campistol, J. Grinyó, 2001, Transplantation.

Two-Dimensional Difference Gel Electrophoresis Urinary Proteomic Profile in the Search of Nonimmune Chronic Allograft Dysfunction Biomarkers

J. Rovira, F. Diekmann, L. Quintana, 2010, Transplantation.

Transcriptional profiling of early onset diet-induced atherosclerosis in apolipoprotein E-deficient mice.

J. Campistol, V. Andrés, C. Castro, 2005, Frontiers in bioscience : a journal and virtual library.

In vivo activation of a conserved microRNA program induces mammalian heart regeneration.

M. Giacca, J. Yates, I. Sancho-Martinez, 2014, Cell stem cell.

Urine Proteomics Biomarkers in Renal Transplantation: An Overview

L. Quintana, J. Campistol, E. Bañon-maneus, 2009, Transplantation.

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

R. Calne, J. Morales, P. Lang, 1999, Transplantation.

Postrenal transplant erythrocytosis and insertion/deletion polymorphism of the angiotensin converting enzyme gene.

F. Oppenheimer, E. Poch, J. Campistol, 1999, Transplantation proceedings.

Distinct Immunohistochemical Phenotype of Nonmelanoma Skin Cancers Between Renal Transplant and Immunocompetent Populations

J. Albanell, I. Revuelta, F. Oppenheimer, 2010, Transplantation.

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration

Edward M. Callaway, Juan Carlos Izpisua Belmonte, Jing Qu, 2016, Nature.

Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass.

J. Rovira, F. Diekmann, J. Campistol, 2007, Journal of the American Society of Nephrology : JASN.

Thrombotic microangiopathies assessment: mind the complement

A. García-Herrera, M. Díaz-Ricart, G. Piñeiro, 2020, Clinical kidney journal.

Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.

T. Cavero, G. Ariceta, J. Campistol, 2015, Kidney international.

Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.

J. Campistol, M. Arias, R. Poveda, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renoprotective Effects of Losartan in Renal Transplant Recipients

R. Saracho, F. Oppenheimer, J. Campistol, 2003, Nephron Clinical Practice.

Early-Onset Anemia After Kidney Transplantation Is an Independent Factor for Graft Loss: A Multicenter, Observational Cohort Study

J. Pascual, D. Serón, J. Morales, 2013, Transplantation.

Nocturnal, every-other-day, online haemodiafiltration: an effective therapeutic alternative.

J. Campistol, N. Fontseré, F. Maduell, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

What Infusion Flow Should Be Used for Mid-Dilution Hemodiafiltration?

J. Campistol, N. Fontseré, F. Maduell, 2010, Blood Purification.

Mid-Dilution Hemodiafiltration: A Comparison with Pre- and Postdilution Modes Using the Same Polyphenylene Membrane

J. Campistol, M. Blasco, N. Fontseré, 2009, Blood Purification.

Glomerular disease after kidney transplantation.

F. Oppenheimer, J. Campistol, J. Vilardell, 1990, Transplantation proceedings.

On-line haemodiafiltration with auto-substitution: assessment of blood flow changes on convective volume and efficiency.

J. Campistol, N. Fontseré, F. Maduell, 2015, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study).

A. Torres, J. Campistol, R. Marcén, 2016, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Chronic allograft nephropathy – a clinical syndrome: early detection and the potential role of proliferation signal inhibitors

J. D. de Fijter, J. Chapman, J. Pascual, 2009, Clinical transplantation.

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

E. Decullier, Jean Kanitakis, S. Euvrard, 2012, The New England journal of medicine.

Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?

J. Campistol, 2006, Nature Clinical Practice Nephrology.

Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.

F. Oppenheimer, J. Campistol, J. Andreu, 1994, Transplantation.

Impact of carotid atherosclerosis as assessed by B-mode ultrasonography on the evolution of kidney transplantation.

E. Ros, F. Oppenheimer, J. Campistol, 2007, Transplantation proceedings.

Renal outcomes of autologous stem cell transplantation among patients with light-chain amyloidosis: a single centre Spanish experience

M. Solé, J. Campistol, J. Bladé, 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

An mTOR‐inhibitor‐based protocol and calcineurin inhibitor (CNI)‐free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI

F. Diekmann, I. Revuelta, F. Oppenheimer, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Erythropoietin safety and efficacy in chronic allograft nephropathy.

J. Campistol, J. Baltar, F. Ortega, 2007, Transplantation proceedings.

Histopathological evaluation of pretransplant donor biopsies in expanded criteria donors with high kidney donor profile index: a retrospective observational cohort study

F. Diekmann, I. Revuelta, M. Solé, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells

F. Prósper, N. Montserrat, J. Penninger, 2022, Cell Metabolism.

Kidney‐specific proteins in patients receiving aprotinin at high‐ and low‐dose regimens during coronary artery bypass graft with cardiopulmonary bypass

J. Campistol, P. Matute, C. Gomar, 2005, European journal of anaesthesiology.

Adjustment of DLCO for hemoglobin concentration.

J. Barberà, J. Roca, R. Rodríguez-Roisín, 1997, American journal of respiratory and critical care medicine.

In vivo partial cellular reprogramming enhances liver plasticity and regeneration

C. Shao, J. I. Izpisúa Belmonte, F. Yi, 2022, Cell reports.

Effect of apolipoprotein polymorphisms in renal transplant recipients.

E. Ros, F. Oppenheimer, J. Campistol, 2003, Transplantation proceedings.

A case of esophageal adenocarcinoma on long‐term rapamycin monotherapy

J. Rovira, F. Diekmann, I. Revuelta, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV‐decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list

X. Forns, M. Bonacci, J. Campistol, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

Treatment With Sirolimus Is Associated With Less Weight Gain After Kidney Transplantation

K. Budde, J. Rovira, F. Diekmann, 2013, Transplantation.

Kidneys From Donors With Incidental Renal Tumors: Should They Be Considered Acceptable Option for Transplantation?

F. Oppenheimer, J. Campistol, D. Paredes, 2013, Transplantation.

Urine proteomics to detect biomarkers for chronic allograft dysfunction.

S. Kalko, F. Diekmann, M. Solé, 2009, Journal of the American Society of Nephrology : JASN.

Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.

J. Campistol, M. Pons, N. Esforzado, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients.

J. Morales, F. Oppenheimer, J. Campistol, 1997, Transplantation.

Muscle angiogenic growth factor gene responses to exercise in chronic renal failure.

Ò. Miró, J. Roca, P. Wagner, 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria.

F. Diekmann, F. Oppenheimer, J. Campistol, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

B Cell-Derived Extracellular Vesicles Reveal Residual B Cell Activity in Kidney Graft Recipients Undergoing Pre-Transplant Desensitization

F. Borràs, J. Rovira, F. Diekmann, 2021, Frontiers in Medicine.

The impact of functional delayed graft function in the modern era of kidney transplantation – A retrospective study

J. Rovira, F. Diekmann, E. Montagud-Marrahi, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

USE OF DE-NOVO mTOR INHIBITORS IN HYPERSENSITZED KIDNEY TRASPLANT RECIPIENTS: EXPERIENCE FROM CLINICAL PRACTICE.

J. Rovira, F. Diekmann, E. Montagud-Marrahi, 2019, Transplantation.

Bortezomib for refractory acute antibody‐mediated rejection in kidney transplant recipients: A single‐centre case series

F. Diekmann, I. Revuelta, M. Lozano, 2016, Nephrology.

MECHANISMS OF NEPHROTOXICITY

J. Campistol, S. Sacks, Barcelona Spain, 2000, Transplantation.

mTOR inhibitor‐associated dermatologic and mucosal problems

J. D. de Fijter, E. Stockfleth, J. Campistol, 2010, Clinical transplantation.

Observational Study of Surveillance Based on the Combination of Online Dialysance and Thermodilution Methods in Hemodialysis Patients with Arteriovenous Fistulas

J. Campistol, N. Fontseré, F. Maduell, 2014, Blood Purification.

Is ionic dialysance useful for early detection of vascular access dysfunction? Six illustrative cases

J. Campistol, M. Blasco, N. Fontseré, 2011, Hemodialysis international. International Symposium on Home Hemodialysis.

[How much should dialysis time be increased when catheters are used?].

J. Campistol, M. Arias, N. Fontseré, 2008, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Influence of the ionic dialysance monitor on Kt measurement in hemodialysis.

J. Campistol, N. Fontseré, F. Maduell, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks.

F. Diekmann, J. Campistol, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.

F. Diekmann, J. Campistol, M. Arias, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

EARLY CYCLOSPORINE WITHDRAWAL FROM A SIROLIMUS-BASED REGIMEN RESULTS IN BETTER RENAL ALLOGRAFT SURVIVAL AND RENAL FUNCTION AT 48 MONTHS AFTER TRANSPLANTATION

G. Russ, A. Hartmann, J. Chapman, 2004, Transplant international : official journal of the European Society for Organ Transplantation.

Sirolimus‐Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years

T. Paavonen, M. Castagneto, J. Campistol, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.

J. Morales, J. Campistol, M. Arias, 2003, Transplantation Proceedings.

Study of kidney rejection following simultaneous kidney-pancreas transplantation.

F. Oppenheimer, J. Campistol, J. Vilardell, 1996, Nephron.

Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial

F. Schena, D. Brennan, R. Oberbauer, 2009, Transplantation.

Effect of pravastatin treatment on the evolution of extracoronary atherosclerosis in renal transplant patients.

E. Ros, F. Oppenheimer, J. Campistol, 2002, Transplantation proceedings.

Influence of renal posttransplantation dyslipidemia on the degree and severity of carotid and femoral atherosclerosis evaluated by B-mode ultrasound.

E. Ros, F. Oppenheimer, J. Campistol, 2002, Transplantation proceedings.

Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis.

F. Oppenheimer, J. Campistol, P. Iñigo, 1999, Transplantation proceedings.

[Non-convulsive status epilepticus secondary to adjusted cefepime doses in patients with chronic renal failure].

J. Campistol, M. Vera, A. Cases, 2000, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

IgA Nephropathy Recurrence after Kidney Transplantation: Role of Recipient Age and Human Leukocyte Antigen-B Mismatch

A. García-Herrera, F. Diekmann, P. Ventura-Aguiar, 2020, American Journal of Nephrology.

Should we be using kidneys from hepatitis C virus-infected donors?

J. Campistol, B. Domínguez-Gil, A. Andrés, 2011, Current opinion in nephrology and hypertension.

Use of hepatitis C–positive donors for kidney transplantation

J. Morales, J. Campistol, B. Domínguez-Gil, 2007 .

Hepatitis C virus infection and kidney transplantation.

J. Morales, J. Campistol, B. Domínguez-Gil, 2002, Seminars in nephrology.

Use of kidneys from anti-HCV positive donors.

J. Morales, F. Oppenheimer, J. Campistol, 2001, Transplantation proceedings.

Hepatitis C virus and renal transplantation

J. Campistol, A. Andrés, J. Rodicio, 1998, Current opinion in nephrology and hypertension.

Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV.

J. Morales, J. Campistol, M. Bruguera, 1995, Kidney international.

Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus

S. Epstein, D. Holt, K. Rutault, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Impact Of Insulin Therapy Before Donation On Graft Outcomes In Pancreas Transplantation: An Analysis Of The Optn/Unos Database.

F. Diekmann, E. Montagud-Marrahi, I. Revuelta, 2021, Diabetes research and clinical practice.

Complement Activation and Thrombotic Microangiopathies.

E. Gratacós, F. Crispi, M. Díaz-Ricart, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Over-expression of muscle glycogen synthase in human diabetic nephropathy

M. Ramírez, C. Caelles, J. Campistol, 2015, Histochemistry and Cell Biology.

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

J. Campistol, J. O. Pestana, F. Vincenti, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney

M. Ramírez, C. Caelles, J. Campistol, 2013, Journal of cellular biochemistry.

Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients

J. Rovira, F. Diekmann, I. Revuelta, 2008, Transplant international : official journal of the European Society for Organ Transplantation.

Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation?

I. Revuelta, F. Oppenheimer, J. Campistol, 2011, NDT plus.

Safety of mTOR inhibitors in adult solid organ transplantation

F. Diekmann, P. Ventura-Aguiar, J. Campistol, 2016, Expert opinion on drug safety.

Effect of a postoperative exercise program on arteriovenous fistula maturation: A randomized controlled trial

J. Campistol, N. Fontseré, F. Maduell, 2016, Hemodialysis international. International Symposium on Home Hemodialysis.

Impaired muscle oxygen transfer in patients with chronic renal failure.

J. Roca, P. Wagner, J. Campistol, 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

D. Serón, J. Herrero, J. Morales, 2014, Transplantation reviews.

Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation.

J. Squifflet, J. Campistol, C. Legendre, 2003, Transplantation proceedings.

Unmasking glucose metabolism alterations in stable renal transplant recipients: a multicenter study.

E. Porrini, A. Torres, J. Campistol, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Outcomes From Brain Death Donors With Previous Cardiac Arrest Accepted for Pancreas Transplantation

C. Fondevila, J. Fuster, J. García-Valdecasas, 2019, Annals of surgery.

Pancreas outcomes between living and deceased kidney donor in pancreas after kidney transplantation patients

J. García-Valdecasas, J. Rovira, F. Diekmann, 2018, Nephrology, Dialysis and Transplantation.

Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant Recipients

J. Morales, J. Campistol, D. Durand, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

N. Kamar, J. Campistol, Y. Vanrenterghem, 2010, Transplantation.

Mammalian Target of Rapamycin Inhibition Prevents Glomerular Hypertrophy in a Model of Renal Mass Reduction

J. Rovira, F. Diekmann, I. Revuelta, 2009, Transplantation.

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.

G. Russ, L. Rostaing, P. Friend, 2006, Journal of the American Society of Nephrology : JASN.

Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.

J. Barberà, J. Roca, R. Rodríguez-Roisín, 1996, The Journal of clinical investigation.

Cellular bioenergetics after erythropoietin therapy in chronic renal failure.

J. Barberà, J. Roca, R. Rodríguez-Roisín, 1996, Journal of Clinical Investigation.

Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score‐matching analysis

F. Diekmann, J. Campistol, F. Oppenheimer, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure.

Ò. Miró, J. Roca, P. Wagner, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.

S. Rodríguez de Córdoba, R. Torra, G. Ariceta, 2015, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

A hybrid data envelopment analysis—artificial neural network prediction model for COVID-19 severity in transplant recipients

Francisco J. Santos-Arteaga, F. Diekmann, D. D. Caprio, 2021, Artificial Intelligence Review.

Hepatitis C virus-positive patients on the waiting list for transplantation: study, evaluation and treatment.

J. Morales, F. Oppenheimer, J. Campistol, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Conversion from calcineurin inhibitors to sirolimus in kidney transplant patients reduces the urinary transforming growth factor-beta1 concentration.

F. Diekmann, S. Lario, F. Oppenheimer, 2007, Transplantation proceedings.

Preemptive simultaneous pancreas kidney transplantation has survival benefit to patient.

F. Diekmann, E. Montagud-Marrahi, I. Revuelta, 2022, Kidney international.

Impact of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Rat Model of Kidney Rejection

J. Rovira, F. Diekmann, P. Ventura-Aguiar, 2020, Frontiers in Cell and Developmental Biology.

Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients.

J. Campistol, L. Guirado, D. del Castillo, 1998, Kidney international. Supplement.

Treatment with angiotensin-converting enzyme inhibitors in renal transplantation with proteinuria.

F. Oppenheimer, J. Campistol, J. Vilardell, 1995, Transplantation proceedings.

Hepatitis C virus infection among kidney transplant recipients.

C. Gil, J. Campistol, M. Bruguera, 1991, Kidney international.

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

E. Nordh, Yi-Chung Lee, R. Sommerville, 2020, Lancet Neurology.

Advanced age donors in the evolution of renal transplantation.

F. Oppenheimer, J. Campistol, J. Vilardell, 1995, Transplantation proceedings.

Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.

J. Morales, F. Oppenheimer, J. Campistol, 1999, Transplantation proceedings.

Borderline rejection in ABO‐incompatible kidney transplantation

F. Diekmann, I. Revuelta, J. Cid, 2016, Clinical transplantation.

Early Cyclosporine A Withdrawal in Kidney-Transplant Recipients Receiving Sirolimus Prevents Progression of Chronic Pathologic Allograft Lesions

J. Morales, J. Campistol, M. Arias, 2004, Transplantation.

A Randomized, Open-Label Study of Sirolimus Versus Cyclosporine in Primary De Novo Renal Allograft Recipients

G. Russ, A. Hartmann, F. Schena, 2013, Transplantation.

Preemptive use of Mammalian target of rapamycin inhibitors in living donor transplantation.

J. Rovira, F. Diekmann, I. Revuelta, 2011, Transplantation proceedings.

Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort Study

M. Juan, J. Miro, J. Rovira, 2022, Transplantation direct.

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

F. Schena, R. Oberbauer, J. Campistol, 2004, Journal of the American Society of Nephrology : JASN.

Rapid SARS-CoV-2 Inactivation in a Simulated Hospital Room Using a Mobile and Autonomous Robot Emitting Ultraviolet-C Light

J. Segalés, J. Vergara-Alert, N. Majó, 2021, The Journal of infectious diseases.

Isolation of Extracellular Vesicles Derived from Mesenchymal Stromal Cells by Ultracentrifugation.

J. Rovira, F. Diekmann, J. Campistol, 2020, Bio-protocol.

Effect of Cinacalcet on Hypercalcemia and Bone Mineral Density in Renal Transplanted Patients With Secondary Hyperparathyroidism

D. Fuster, F. Oppenheimer, J. Campistol, 2008, Transplantation.

Sirolimus monotherapy as maintenance immunosuppression: single-center experience in 50 kidney transplant patients.

J. Rovira, F. Diekmann, F. Oppenheimer, 2007, Transplantation proceedings.

USE OF DE-NOVO mTOR INHIBITORS IN HYPERSENSITZED KIDNEY TRASPLANT RECIPIENTS: EXPERIENCE FROM CLINICAL PRACTICE.

J. Rovira, F. Diekmann, E. Montagud-Marrahi, 2019, Transplantation.

Minimizing the risk of posttransplant malignancy.

J. Campistol, 2008, Transplantation proceedings.

Malignancy in renal transplantation: opportunities with proliferation signal inhibitors Guest editors’ introduction

J. Chapman, J. Campistol, 2007 .

Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years.

D. Serón, J. Morales, F. Oppenheimer, 2006, Transplantation Proceedings.

A novel assay to measure calcification propensity: from laboratory to humans

J. Campistol, A. Gold, J. Perelló, 2020, Scientific Reports.

Renal Dysfunction in the Setting of HIV/AIDS

J. Miro, J. Gatell, F. Oppenheimer, 2012, Current HIV/AIDS Reports.

Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial

F. Schena, J. Campistol, J. Korth-Bradley, 2011, Transplantation.

Cyclosporine A Inhibits the T‐bet–Dependent Antitumor Response of CD8+ T Cells

G. Koehl, E. Geissler, J. Rovira, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Minimizing the Risk of Posttransplant Malignancy

J. Campistol, 2009, Transplantation.

Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.

F. Schena, J. Campistol, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Sirolimus monotherapy: feasible immunosuppression for long-term follow-up of kidney transplantation--a pilot experience.

F. Diekmann, F. Oppenheimer, J. Campistol, 2005, Transplantation.

Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma.

F. Oppenheimer, J. Campistol, F. Oppenheimer, 2005, Transplantation proceedings.

Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.

F. Schena, G. Nanni, J. Morales, 2005, Transplantation proceedings.

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.

J. Campistol, J. Torregrosa, Á. Gutiérrez-Dalmau, 2004, Transplantation.

Renal transplantation for dialysis amyloidosis.

F. Oppenheimer, J. Campistol, J. Vilardell, 1992, Transplantation proceedings.

Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease.

D. Serón, J. Morales, F. Oppenheimer, 2008, Kidney international. Supplement.

An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.

S. Rodríguez de Córdoba, R. Torra, G. Ariceta, 2015, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation

Z. Demko, J. Rovira, F. Diekmann, 2022, Transplantation.

The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation

F. Diekmann, L. Quintana, E. Poch, 2017, Clinical kidney journal.

Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy

F. Diekmann, L. Quintana, F. Oppenheimer, 2015, Transplantation.

Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes

R. Selgas, A. Torres, J. Campistol, 2011, Clinical chemistry and laboratory medicine.

Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.

R. Calne, J. Morales, J. Campistol, 2003, Transplantation proceedings.

Role of HHV‐8 and mTOR pathway in post‐transplant Kaposi sarcoma staging

A. Petit, J. Rovira, F. Diekmann, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy

A. García-Herrera, M. Díaz-Ricart, L. Quintana, 2020, British journal of haematology.

Sirolimus-Associated Testicular Toxicity: Detrimental But Reversible

J. Rovira, F. Diekmann, J. Campistol, 2012, Transplantation.

mTOR inhibition and erythropoiesis: microcytosis or anaemia?

M. Díaz-Ricart, G. Escolar, J. Rovira, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Practical recommendations for the early use of m‐TOR inhibitors (sirolimus) in renal transplantation

F. Diekmann, D. Donati, J. Campistol, 2009, Transplant international : official journal of the European Society for Organ Transplantation.

Weekly risedronate in kidney transplant patients with osteopenia

D. Fuster, F. Diekmann, F. Oppenheimer, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.

F. Diekmann, I. Revuelta, M. Lozano, 2015, Transplantation proceedings.

Pilot Randomized Study of Early Tacrolimus Withdrawal from a Regimen with Sirolimus Plus Tacrolimus in Kidney Transplantation

J. Morales, J. Campistol, M. Arias, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.

F. Oppenheimer, J. Campistol, M. Brunet, 2003, Transplantation proceedings.

Kidney Transplantation from Donors with a Positive Serology for Hepatitis C: The Facts and the Challenges

J. Morales, J. Campistol, B. Domínguez-Gil, 2010 .

Immunosuppression in Older Renal Transplant Patients

J. Morales, J. Campistol, A. Andrés, 2000, Drugs & aging.

Long-term maintenance therapy with calcineurin inhibitors: an update.

J. Campistol, 2010, Transplantation proceedings.

Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation.

F. Diekmann, F. Oppenheimer, J. Campistol, 2007, Transplantation.

Early cyclosporine withdrawal from a sirolimus‐based regimen results in better renal allograft survival and renal function at 48 months after transplantation

G. Russ, A. Hartmann, J. Chapman, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome.

M. Solé, F. Oppenheimer, J. Campistol, 2004, Transplantation proceedings.

Hepatitis C virus-positive patients on the waiting list for transplantation.

J. Morales, J. Campistol, N. Esforzado, 2002, Seminars in nephrology.

Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade.

J. Campistol, J. Paul, Á. Gutiérrez-Dalmau, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management

M. Solé, L. Quintana, J. Campistol, 2015, Journal of Nephrology.

Outcomes in older kidney recipients from older donors: A propensity score analysis

F. Diekmann, E. Montagud-Marrahi, I. Revuelta, 2022, Frontiers in Nephrology.

The Influence of Innate Immunity Gene Receptors Polymorphisms in Renal Transplant Infections

T. Pumarola, F. Oppenheimer, J. Campistol, 2007, Transplantation.

First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma

M. Juan, M. Lozano, J. Cid, 2021, Journal for ImmunoTherapy of Cancer.

Elimination of Large Uremic Toxins by a Dialyzer Specifically Designed for High-Volume Convective Therapies

J. Campistol, M. Arias-Guillén, N. Fontseré, 2014, Blood Purification.

Differences between acute and chronic renal graft rejection on immunohistochemical staining of transforming growth factor beta-1.

M. Solé, F. Oppenheimer, J. Campistol, 1999, Transplantation proceedings.

Treatment of hepatitis C in dialysis patients.

J. Campistol, N. Esforzado, 2012, Contributions to nephrology.

Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus.

J. Morales, J. Campistol, M. Arias, 2008, Transplantation.

Anti-C5 as prophylactic therapy in atypical hemolytic uremic syndrome in living-related kidney transplantation.

F. Diekmann, F. Oppenheimer, J. Campistol, 2013, Transplantation.

Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.

G. Escolar, F. Oppenheimer, J. Campistol, 2010, Transplantation.

Renal transplantation from donors with a positive serology for hepatitis C.

J. Morales, J. Campistol, B. Domínguez-Gil, 2012, Contributions to nephrology.

Uremic myopathy.

J. Campistol, 2002, Kidney international.

Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.

C. Gil, J. Campistol, M. Bruguera, 1991, Transplantation proceedings.

Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome

J. Campistol, M. Blasco, F. Maduell, 2012, Clinical kidney journal.

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis

G. Remuzzi, T. Feldkamp, N. Sheerin, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)

R. Martino, E. Montagud-Marrahi, L. Quintana, 2020, Annals of Hematology.

Renal transplantation in patients with hepatitis C virus antibody. A long national experience

D. Serón, J. Morales, F. Oppenheimer, 2010, NDT plus.

Utility of pulsed Doppler in the diagnosis and follow-up of acute vascular graft rejection treated with OKT3 monoclonal antibody or antilymphocyte serum.

J. Campistol, J. Vilardell, R. Gilabert, 1991, Transplantation.

Renal cell carcinoma and acquired cystic kidney disease after renal transplantation

J. Campistol, J. Vilardell, J. Almirall, 1990, Transplant international : official journal of the European Society for Organ Transplantation.

Interspecies Chimerism with Mammalian Pluripotent Stem Cells

J. C. Belmonte, J. I. Izpisúa Belmonte, Keiichiro Suzuki, 2017, Cell.

Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.

J. Campistol, M. Blasco, A. Cases, 2012, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates.

J. Campistol, M. Blasco, J. Torregrosa, 2013, Clinical nephrology.

Three‐Year Outcomes From BENEFIT‐EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

M. Schnitzler, R. Manfro, N. Kamar, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

S. Chadban, P. Marchetti, A. Więcek, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Compression of the ulnar nerve in Guyon’s canal by uremic tumoral calcinosis

F. Oppenheimer, J. Campistol, F. Cofán, 2000, Archives of Orthopaedic and Trauma Surgery.

Pathophysiology CKD 5D

P. Jagodziński, A. Lupo, O. Iba, 2012 .

Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy.

F. Oppenheimer, J. Campistol, F. Cofán, 1999, The Journal of rheumatology.

Risk Factors for Infection with Extended‐Spectrum and AmpC β‐Lactamase‐Producing Gram‐Negative Rods in Renal Transplantation

F. Oppenheimer, J. Campistol, A. Moreno, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation.

F. Oppenheimer, J. Campistol, V. Torregrosa, 2007, Transplantation proceedings.

Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics

E. Gratacós, F. Crispi, M. Díaz-Ricart, 2021, Scientific Reports.

Pulmonary acremonium abscesses and gastrointestinal tuberculosis manifested as massive upper gastrointestinal bleeding.

Ò. Miró, J. Nicolás, J. Campistol, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Extracorporeal Photopheresis Improves Graft Survival in a Full-Mismatch Rat Model of Kidney Transplantation

J. Rovira, F. Diekmann, E. Montagud-Marrahi, 2023, Transplant International.

Renal transplantation in HIV-infected patients: 2010 update.

J. Miro, F. Oppenheimer, J. Campistol, 2011, Kidney international.

Ulnar nerve compression--a case of giant uremic tumoral calcinosis.

F. Oppenheimer, J. Campistol, F. Cofán, 1997, Acta orthopaedica Scandinavica.

Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus.

J. Campistol, M. Budruddin, M. Khalil, 2007, Transplantation proceedings.

New concepts and best practices for management of pre- and post-transplantation cancer.

D. Serón, J. Herrero, J. Morales, 2012, Transplantation reviews.

Proliferation signal inhibitors and post‐transplant malignancies in heart transplantation: practical clinical management questions

H. Valantine, J. Albanell, L. Potena, 2011, Clinical transplantation.

Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.

D. Serón, J. Morales, F. Oppenheimer, 2007, Transplantation proceedings.

Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells

Dobryna Zalvidea, Xavier Trepat, Elena Garreta, 2019, Nature Materials.

Evolving trends in induction therapy.

J. Campistol, F. Vincenti, M. Arias, 2009, Transplantation reviews.

Renal Transplantation and Cancer: Focus on Immunosuppressive Therapy

I. Revuelta, J. Campistol, Á. Gutiérrez-Dalmau, 2007 .

À. Argilés, J. Campistol, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A phase 1b randomized, placebo‐controlled clinical trial with SNF472 in haemodialysis patients

J. Campistol, V. Torregrosa, P. Joubert, 2019, British journal of clinical pharmacology.

Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network.

J. I. Izpisúa Belmonte, Keiichiro Suzuki, C. Khor, 2019, Cell stem cell.

3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic Progenitors.

I. Pastan, J. I. Izpisúa Belmonte, Mo Li, 2016, Cell stem cell.

Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features

M. Solé, J. Campistol, J. Caballería, 2001, American Journal of Gastroenterology.

Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy

Ò. Miró, J. Fernandez-Solà, J. Campistol, 1996 .

An alternative pluripotent state confers interspecies chimaeric competency

Juan Carlos Izpisua Belmonte, Joseph R. Ecker, Yupeng He, 2015, Nature.

The copy number variation landscape of congenital anomalies of the kidney and urinary tract

Craig S. Wong, H. Hakonarson, A. Latos-Bieleńska, 2018, Nature Genetics.

The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor–like cells

Josep Maria Campistol, Juan Carlos Izpisua Belmonte, I. Sancho-Martinez, 2014, Nature Protocols.

In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation

C. R. Esteban, P. Reddy, P. Guillen, 2017, Cell.

Identification of Novel Long Noncoding RNAs Underlying Vertebrate Cardiovascular Development

Gene W. Yeo, I. Sancho-Martinez, C. Benner, 2015, Circulation.

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming

C. R. Esteban, P. Reddy, Tomoaki Hishida, 2016, Cell.

Tissue engineering by decellularization and 3D bioprinting

Josep Samitier, Francisco Fernández-Avilés, Elena Garreta, 2017 .

Generation of Induced Pluripotent Stem Cells from Human Renal Proximal Tubular Cells with Only Two Transcription Factors, Oct4 and Sox2*

I. Sancho-Martinez, J. I. Izpisúa Belmonte, N. Montserrat, 2012, The Journal of Biological Chemistry.

Generation of Induced Pluripotent Stem Cells from Human Renal Proximal Tubular Cells with Only Two Transcription

I. Sancho-Martinez, N. Montserrat, J. Campistol, 2012 .

Generation of Induced Pluripotent Stem Cells from Human Renal Proximal Tubular Cells with Only Two Transcription Factors , Oct 4 and Sox 2 *

I. Sancho-Martinez, N. Montserrat, J. Campistol, 2012 .

Nephroprotective Potential of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Murine Model of Chronic Cyclosporine Nephrotoxicity

G. Camussi, J. Rovira, F. Diekmann, 2020, Frontiers in Cell and Developmental Biology.

Effect of immunosuppression in miRNAs from extracellular vesicles of colorectal cancer and their influence on the pre-metastatic niche

H. D. del Portillo, J. Rovira, F. Diekmann, 2019, Scientific Reports.

Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions

J. Pascual, J. Campistol, I. Boletis, 2006 .

Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)

H. Neumayer, P. Lang, J. Campistol, 2011, Transplantation.

Pattern of renal dysfunction associated with myocardial revascularization surgery and cardiopulmonary bypass

J. Campistol, P. Matute, C. Gomar, 2003, European journal of anaesthesiology.

KCNQ1 gene variants and risk of new‐onset diabetes in tacrolimus‐treated renal‐transplanted patients

V. Álvarez, E. Coto, R. Selgas, 2011, Clinical transplantation.

Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway.

F. Sánchez‐Madrid, J. Campistol, V. Andrés, 2004, Atherosclerosis.

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

P. Ruggenenti, C. Bedrosian, A. Gaber, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.

J. Albanell, J. D. de Fijter, J. Chapman, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults

N. Heyne, Y. Miyakawa, G. Ariceta, 2021, Kidney international reports.

Immune Profiling of Peripheral Blood Mononuclear Cells at Pancreas Acute Rejection Episodes in Kidney-Pancreas Transplant Recipients

J. Rovira, F. Diekmann, E. Montagud-Marrahi, 2022, Transplant International.

Fatty acid composition of low-density lipoprotein in renal transplant recipients treated with cyclosporine.

E. Ros, F. Oppenheimer, J. Campistol, 2002, Transplantation proceedings.

F. Oppenheimer, J. Campistol, A. Moreno, 2007, Transplantation proceedings.

Pre-Emptive Retransplantation in Patients With Chronic Kidney Graft Failure.

F. Diekmann, I. Revuelta, F. Oppenheimer, 2015, Transplantation proceedings.

Feasibility of transvaginal natural orifice transluminal endoscopic surgery-assisted living donor nephrectomy: is kidney vaginal delivery the approach of the future?

F. Oppenheimer, J. Campistol, A. Alcaraz, 2011, European urology.

Long-term mycophenolate monotherapy in human leukocyte antigen (HLA)-identical living-donor kidney transplantation

F. Diekmann, I. Revuelta, L. Quintana, 2014, Transplantation research.

Lymphoplasmacytic lymphoma causing light chain cast nephropathy.

A. García-Herrera, G. Espinosa, M. Solé, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection

J. Rovira, F. Diekmann, I. Revuelta, 2018, BMC Nephrology.

Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy.

H. Valantine, J. Albanell, H. Lehmkuhl, 2007, Transplantation proceedings.

The role of proliferation signal inhibitors in post-transplant malignancies.

J. Campistol, Á. Gutiérrez-Dalmau, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review

F. Oppenheimer, J. Campistol, F. Cofán, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

The Search for a New Marker of Renal Function in Older Patients with Chronic Kidney Disease Stages 3–4: Usefulness of Cystatin C-Based Equations

J. Campistol, R. Deulofeu, N. Fontseré, 2009, Nephron Clinical Practice.

Earlier Decrease of FGF-23 and Less Hypophosphatemia in Preemptive Kidney Transplant Recipients

J. Campistol, G. Casals, J. Torregrosa, 2012, Transplantation.

Predictors of Success in Conversion from Calcineurin Inhibitor to Sirolimus in Chronic Allograft Dysfunction

K. Budde, F. Diekmann, H. Neumayer, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Therapeutic application of extracellular vesicles in acute and chronic renal injury.

J. Rovira, F. Diekmann, J. Campistol, 2017 .

Combination of calcineurin and mTOR inhibitors in kidney transplantation: a propensity score analysis based on current clinical practice

J. Rovira, F. Diekmann, E. Montagud-Marrahi, 2019, Journal of Nephrology.

'Old-for-old'--new strategies for renal transplantation.

J. Campistol, F. Citterio, W. Arns, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

RISING AGE LIMIT FOR KIDNEY DONORS

F. Oppenheimer, J. Campistol, J. Vilardell, 1989, The Lancet.

Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C(2).

J. Martorell., F. Oppenheimer, J. Campistol, 2003, International immunopharmacology.

Primary brain lymphomas after kidney transplantation: an under-recognized problem?

A. López-Guillermo, F. Diekmann, N. Solà-Valls, 2014, Journal of Nephrology.

Polymicrobial Peritonitis in a Patient with Mixed Cryoglobulinemia

J. Campistol, M. Vera, N. Serra, 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Everolimus and Long-Term Outcomes in Renal Transplantation

J. D. de Fijter, H. Holdaas, J. Campistol, 2011, Transplantation.

Conclusions from the symposium.

J. Campistol, 2010, Transplantation proceedings.

Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study.

F. Diekmann, J. Campistol, M. Arias, 2005, Transplantation proceedings.

Over-expression of muscle glycogen synthase in human diabetic nephropathy

M. Ramírez, C. Caelles, J. Campistol, 2015, Histochemistry and Cell Biology.

Front & Back Matter

M. Bottai, J. Ärnlöv, J. Carrero, 2012, Blood Purification.

Dialysate calcium individualisation: a pending issue.

J. Campistol, M. Arias-Guillén, N. Fontseré, 2012, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Set point of calcium in severe secondary hyperparathyroidism is altered and does not change after successful kidney transplantation

D. Rubello, D. Fuster, F. Oppenheimer, 2015, Endocrine.

[Compression of the sciatic nerve in uremic tumor calcinosis].

F. Oppenheimer, J. Campistol, F. Cofán, 1999, Neurologia.

Economic analysis of the treatment of end-stage renal disease treatment: living-donor kidney transplantation versus hemodialysis.

F. Diekmann, I. Revuelta, F. Oppenheimer, 2015, Transplantation proceedings.

Pre‐implantation analysis of kidney biopsies from expanded criteria donors: testing the accuracy of frozen section technique and the adequacy of their assessment by on‐call pathologists

M. Solé, J. Campistol, F. Oppenheimer, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?

F. Diekmann, I. Revuelta, P. Ventura-Aguiar, 2020, American Journal of Transplantation.

Chronic lymphedema in renal transplant recipients under immunosuppression with sirolimus: presentation of 2 cases.

J. Campistol, N. Esforzado, J. Mascaró, 2014, JAMA dermatology.

Comparison of the long-term outcomes of kidney transplantation: USAversus Spain

F. Luan, R. Merion, A. Ojo, 2013 .

Comparison of the long-term outcomes of kidney transplantation: USA versus Spain.

F. Luan, R. Merion, A. Ojo, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Total hip arthroplasty in hemodialysis and renal transplant patients.

F. Oppenheimer, J. Campistol, F. Cofán, 2008, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

Total hip arthroplasty in hemodialysis and renal transplant patients

F. Oppenheimer, J. Campistol, F. Cofán, 2008 .

[Pharmacogenetics of angiotensin system in non diabetic nephropathy].

V. Álvarez, E. Coto, J. Campistol, 2005, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients.

J. Campistol, V. Andrés, C. Castro, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection

J. Rovira, F. Diekmann, I. Revuelta, 2018, Transplantation.

Erythropoietin resistance as surrogate marker of graft and patient survival in renal transplantation: 3-year prospective multicenter study.

J. Campistol, M. Arias, G. Fernández‐Fresnedo, 2010, Transplantation proceedings.

Prevalence and clinical characteristics of renal transplant patients with true resistant hypertension

J. Campistol, A. Franco, G. Fernández‐Fresnedo, 2015, Journal of hypertension.

Urinary Proteomics and Renal Transplantation

L. Quintana, J. Campistol, E. Bañon-maneus, 2011 .

Once-monthly pegylated epoetin Beta versus darbepoetin alfa every two weeks in renal transplant recipients: a randomized trial.

J. Morales, J. Campistol, M. Arias, 2013, Transplantation.

Clinical profile and post-transplant anaemia in renal transplant recipients restarting dialysis after a failed graft: changing trends between 2001 and 2009

J. Campistol, M. Arias, L. Guirado, 2013, Clinical kidney journal.

Quality of life of patients with chronic renal allograft rejection and anemia.

J. Campistol, J. Baltar, P. Rebollo, 2004, Journal of nephrology.

Research on Skeletal Muscle Diseases Using Pluripotent Stem Cells

J. Campistol, E. Garreta, J. Gutiérrez, 2015 .

Estimation of renal allograft half-life: fact or fiction?

F. Moreso, D. Serón, J. Morales, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Conversion to sirolimus for chronic allograft dysfunction: long‐term results confirm predictive value of proteinuria

T. Slowinski, K. Budde, F. Diekmann, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Application of Label-free Quantitative Peptidomics for the Identification of Urinary Biomarkers of Kidney Chronic Allograft Dysfunction*

Pedro R Cutillas, Maria P Alcolea, Josep M Campistol, 2009, Molecular & Cellular Proteomics.

Effect of calcineurin inhibitors on low-density lipoprotein oxidation.

F. Oppenheimer, J. Campistol, F. Cofán, 2005, Transplantation proceedings.

Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice

D. Navarro, F. Moreso, J. Campistol, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

Hepatitis C virus and organ transplantation.

J. Morales, J. Campistol, A. Andrés, 1993, New England Journal of Medicine.

Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols.

F. Diekmann, F. Oppenheimer, J. Campistol, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome

J. Rovira, F. Diekmann, A. Torres, 2016, Transplantation direct.

Practical considerations for the use of mTOR inhibitors

F. Diekmann, J. Campistol, 2015, Transplantation research.

Sotrastaurin in Calcineurin Inhibitor–Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients

G. Russ, A. Hartmann, K. Budde, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation

B. Kasiske, G. Russ, M. Pescovitz, 2012, Journal of transplantation.

Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy

J. Lozano, J. Campistol, F. Oppenheimer, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Sirolimus: a potential option for the prevention of chronic allograft nephropathy

J. Campistol, 2003 .

Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.

F. Oppenheimer, J. Campistol, J. Torregrosa, 2007, Transplantation proceedings.

Practical Utility of On-Line Clearance and Blood Temperature Monitors as Noninvasive Techniques to Measure Hemodialysis Blood Access Flow

Josep M. Campistol, J. Campistol, M. Blasco, 2010, Blood Purification.

Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.

W. Jiménez, F. Rivera, S. Lario, 1999, Kidney international.

Withdrawal of cinacalcet at the time of renal transplantation is not a risk factor for allograft calcifications in the early posttransplantation period.

J. Campistol, X. Barros, R. Paschoalin, 2012, Transplantation proceedings.

Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.

F. Oppenheimer, J. Campistol, J. Torregrosa, 2009, Transplantation proceedings.

Outcomes of hip arthroplasty in patients with end-stage renal disease: a retrospective, controlled study.

F. Oppenheimer, J. Campistol, F. Cofán, 2015 .

Modeling Patients as Dynamical Systems: Evaluating the Efficiency of Kidney Transplantation through Multi-Stage Data Envelopment Analysis

David Cucchiari, Santos Arteaga Fj, D DiCaprio, 2019 .

Sympathetic dystrophy associated with sirolimus therapy.

F. Diekmann, F. Oppenheimer, J. Campistol, 2008, Transplantation.

Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy.

Ò. Miró, J. Fernandez-Solà, J. Campistol, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Pregnancy in a Renal Transplant Recipient with HIV-1 Infection: A Case Report

J. Miro, J. Campistol, F. Oppenheimer, 2016, Antiviral therapy.

Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine

T. Pumarola, L. Quintana, J. Campistol, 2012, Influenza and other respiratory viruses.

Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients.

J. Miro, J. Campistol, F. Oppenheimer, 2007, AIDS research and human retroviruses.

Renal cortical necrosis after kidney transplantation associated with the prothrombin 20210A mutation.

L. Quintana, F. Oppenheimer, J. Campistol, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

αKLOTHO and sTGFβR2 treatment counteract the osteoarthritic phenotype developed in a rat model

G. Church, C. R. Esteban, M. Shokhirev, 2020, Protein & Cell.

Role of Oncogenic Pathways and KRAS/BRAF Mutations in the Behavior of Colon Adenocarcinoma in Renal Transplant Patients

A. García-Herrera, J. Albanell, J. Rovira, 2012, Transplantation.

[Minimizing the risk of cancer in transplant patients].

J. Campistol, 2010, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

Long‐Term Experience With Kidney Transplantation From Hepatitis C‐Positive Donors Into Hepatitis C‐Positive Recipients

J M Morales, J. Morales, F. Oppenheimer, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Tunneled Catheters with Taurolidine-Citrate-Heparin Lock Solution Significantly Improve the Inflammatory Profile of Hemodialysis Patients

Á. Soriano, J. Navarro-González, J. Campistol, 2014, Antimicrobial Agents and Chemotherapy.

Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus.

V. Álvarez, E. Coto, A. Ortiz, 2012, Molecular genetics and metabolism.

Glomerular diseases in patients with hepatitis C virus infection after renal transplantation.

J. Morales, J. Campistol, A. Andrés, 1997, Current opinion in nephrology and hypertension.

High Incidence of Paralytic Ileus After Bortezomib Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients: Report of 2 Cases.

F. Diekmann, I. Revuelta, M. Lozano, 2015, Transplantation.

Early cyclosporine a withdrawal in kidney transplant recipients under a sirolimus-based immunosuppressive regimen: pathological study of graft biopsies at 1-year posttransplant.

J. Morales, J. Campistol, M. Arias, 2002, Transplantation proceedings.

Sensitivity of Blood Volume Monitoring for Fluid Status Assessment in Hemodialysis Patients

J. Campistol, N. Fontseré, M. Carrera, 2013, Blood Purification.

Sirolimus monotherapy as maintenance immunosuppression: a multicenter experience

F. Diekmann, J. Morales, J. Campistol, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

A Novel Risk Score for Mortality in Renal Transplant Recipients Beyond the First Posttransplant Year

A. Torres, F. Moreso, D. Serón, 2009, Transplantation.

Impact of Discards for Living Donor Kidney Transplantation in a Transplant Program.

F. Diekmann, I. Revuelta, D. Cucchiari, 2019, Transplantation proceedings.

Mutations in foregut SOX2+ cells induce efficient proliferation via CXCR2 pathway

I. Sancho-Martinez, J. I. Izpisúa Belmonte, C. Benner, 2019, Protein & Cell.

Influence of Persistent Inflammation in Follow-Up Biopsies After Antibody-Mediated Rejection in Kidney Transplantation

J. Rovira, F. Diekmann, E. Montagud-Marrahi, 2021, Frontiers in Medicine.

Pravastatin improves low-density lipoprotein oxidation in renal transplantation.

E. Ros, F. Oppenheimer, J. Campistol, 2002, Transplantation proceedings.

Early sirolimus use with cyclosporine elimination does not induce progressive proteinuria.

J. Morales, J. Campistol, M. Arias, 2007, Transplantation proceedings.

Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology.

M. Juan, J. Yagüe, F. Diekmann, 2017, Immunobiology.

Three-Year Outcomes in Patients with Delayed Graft Function in Phase III Studies of Belatacept Vs Cyclosporine in Kidney Transplantation (BENEFIT and BENEFIT-EXT): 1853

K. Budde, L. Pupim, J. Campistol, 2012 .

Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes

V. Álvarez, E. Coto, R. Selgas, 2011 .

Renal transplantation in elderly recipients : IInd congress of the Catalan Transplantation Society, Barcelona, Spain, February 18-20, 1991

F. Oppenheimer, J. Campistol, J. Vilardell, 1992 .

Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single center cohort of kidney recipients

F. Diekmann, E. Montagud-Marrahi, I. Revuelta, 2020, American Journal of Transplantation.

Chimeric HLA antibody receptor T cells for targeted therapy of antibody‐mediated rejection in transplantation

M. Juan, F. Claas, J. Rovira, 2023, HLA.

Thermodilution versus Saline Dilution Method for Vascular Access Blood Flow Measurement in High-Flux and On-Line Hemodiafiltration

J. Campistol, M. Blasco, N. Fontseré, 2012, The journal of vascular access.

Mammalian target of rapamycin and diabetes: what does the current evidence tell us?

J. Rovira, J. Campistol, B. Vodenik, 2009, Transplantation proceedings.

Reflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with tacrolimus.

D. Fuster, F. Oppenheimer, J. Campistol, 2003, Transplantation Proceedings.

Prospective Observational Study of Sirolimus as Primary Immunosuppression After Renal Transplantation

B. Kasiske, G. Russ, M. Pescovitz, 2009, Transplantation.

Policies concerning the use of kidneys from donors infected with hepatitis C virus.

F. Oppenheimer, J. Campistol, M. Bruguera, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Kidney transplant from a monozygotic twin living donor with no maintenance immunosuppression

F. Diekmann, I. Revuelta, F. Oppenheimer, 2015 .

Kidney transplant from a living monozygotic twin donor with no maintenance immunosuppression.

F. Diekmann, I. Revuelta, F. Oppenheimer, 2015, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Are HIV-infected donors suitable for renal transplantation?

J. Miro, F. Oppenheimer, J. Campistol, 2011, Transplantation.

Kidney transplantation and waiting list for renal transplantation for human immunodeficiency virus patients.

F. Oppenheimer, J. Campistol, A. Moreno, 2011, Transplantation proceedings.

Practical utility of thermodilution versus doppler ultrasound to measure hemodialysis blood access flow.

J. Campistol, N. Fontseré, F. Maduell, 2013, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Desensitization in ABO-Incompatible Kidney Transplantation With Low ABO Iso-Agglutinin Titers.

F. Diekmann, I. Revuelta, J. Cid, 2015, Transplantation proceedings.